X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (423) 423
Publication (95) 95
Patent (43) 43
Book / eBook (17) 17
Newspaper Article (16) 16
Book Chapter (15) 15
Conference Proceeding (9) 9
Dissertation (9) 9
Magazine Article (7) 7
Book Review (2) 2
Trade Publication Article (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (181) 181
index medicus (135) 135
female (94) 94
male (88) 88
adult (74) 74
middle aged (68) 68
clinical neurology (55) 55
neurofibromatosis (49) 49
microbiology (44) 44
physics (44) 44
testing (43) 43
beer (42) 42
biochemistry (42) 42
chemistry (42) 42
compositions or test papers therefor (42) 42
condition-responsive control in microbiological orenzymological processes (42) 42
enzymology (42) 42
investigating or analysing materials by determining theirchemical or physical properties (42) 42
measuring (42) 42
measuring or testing processes involving enzymes, nucleicacids or microorganisms (42) 42
metallurgy (42) 42
mutation or genetic engineering (42) 42
processes of preparing such compositions (42) 42
spirits (42) 42
vinegar (42) 42
wine (42) 42
aged (41) 41
oncology (39) 39
adolescent (34) 34
animals (34) 34
article (31) 31
tumors (30) 30
young adult (28) 28
cancer (26) 26
magnetic resonance imaging (25) 25
pediatrics (25) 25
abridged index medicus (24) 24
child (24) 24
treatment outcome (24) 24
neurosciences (22) 22
schwannomatosis (22) 22
neurology (21) 21
genetics & heredity (20) 20
mice (20) 20
type-1 (20) 20
astrophysics (19) 19
bevacizumab (18) 18
neurofibromatosis 2 (18) 18
retrospective studies (18) 18
astronomy & astrophysics (17) 17
care and treatment (17) 17
management (17) 17
medicine & public health (17) 17
nf2 (17) 17
otorhinolaryngologic diseases (17) 17
computer science (15) 15
computer science, theory & methods (15) 15
cosmology and extragalactic astrophysics (15) 15
follow-up studies (15) 15
high energy astrophysical phenomena (15) 15
mutation (15) 15
neurofibromatosis 2 - pathology (15) 15
research (15) 15
risk factors (15) 15
children (14) 14
diagnosis (14) 14
general tagging of cross-sectional technologies spanning over several sections of the ipc (14) 14
general tagging of new technological developments (14) 14
multidisciplinary sciences (14) 14
prognosis (14) 14
surgery (14) 14
technical subjects covered by former uspc (14) 14
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (14) 14
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (14) 14
abstracts (13) 13
active galactic nuclei (13) 13
brain (13) 13
immunology (13) 13
meningioma (13) 13
patients (13) 13
prevention (13) 13
schwannoma (13) 13
therapy (13) 13
aged, 80 and over (12) 12
analysis (12) 12
astrophysics - cosmology and nongalactic astrophysics (12) 12
galaxy astrophysics (12) 12
health aspects (12) 12
neurilemmoma - genetics (12) 12
neurofibromatosis 2 - complications (12) 12
neurofibromatosis 2 - genetics (12) 12
quality of life (12) 12
theoretical computer science (12) 12
brain neoplasms - drug therapy (11) 11
chemotherapy (11) 11
child, preschool (11) 11
digital sky survey (11) 11
galaxies: active (11) 11
infant (11) 11
medical research (11) 11
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Gerstein Science - Stacks (4) 4
Robarts - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Mathematical Sciences - May be requested in 6-10 wks (1) 1
OISE - Stacks (1) 1
Online Resources - Online (1) 1
Robarts - Searching (1) 1
Stacks (1) 1
West Park Healthcare Centre - Pharmacy (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (519) 519
French (18) 18
German (18) 18
Spanish (4) 4
Portuguese (3) 3
Danish (2) 2
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Theoretical Computer Science, ISSN 0304-3975, 08/2014, Volume 546, Issue C, pp. 17 - 29
We classify all sub-cartesian closed categories of the category of separable Scott domains. The classification employs a notion of coherence degree determined... 
Cartesian closed category | Scott domain | Lambda calculus | COMPUTER SCIENCE, THEORY & METHODS
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e35711
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0197350
Neurofibromatosis 2 (NF2) is a rare tumor suppressor syndrome that manifests with multiple schwannomas and meningiomas. There are no effective drug therapies... 
MOLECULE INHIBITOR | LAPATINIB | HISTONE DEACETYLASE INHIBITOR | ACTIVATION | MULTIDISCIPLINARY SCIENCES | THERAPEUTIC TARGET | PHASE-II | GROWTH-FACTOR | KINASE INHIBITOR | MENINGIOMA CELLS | VESTIBULAR SCHWANNOMAS | Neurofibromatosis 2 - drug therapy | Cell Survival - drug effects | Neurofibromin 2 - genetics | Meningeal Neoplasms - genetics | Humans | Panobinostat - pharmacology | Carcinogenesis - genetics | Gene Expression Regulation, Neoplastic | Morpholines - pharmacology | Transcriptome - genetics | Neurofibromatosis 2 - genetics | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Systems Biology | Neurilemmoma - pathology | Quinolines - pharmacology | Neurofibromatosis 2 - pathology | Animals | Meningeal Neoplasms - drug therapy | Neurilemmoma - drug therapy | Neurilemmoma - genetics | Cell Line, Tumor | Mice | Meningeal Neoplasms - pathology | Genetic aspects | Drug discovery | Research | Drug therapy | Systems biology | Neurofibromatosis | Cell culture | Pediatrics | Neurofibromin 2 | Neurofibromatosis 2 | Biology | Kinases | Medical schools | Consortia | Tumorigenesis | Bioinformatics | Phenotypes | Schwann cells | Breast cancer | Gene expression | Medical screening | Molecular chains | Children & youth | Medicine | Hospitals | Tumor suppressor genes | Blood diseases | Viability | Meningioma | Tumors
Journal Article
Seminars in Neurology, ISSN 0271-8235, 02/2018, Volume 38, Issue 1, pp. 073 - 085
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e59941
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2013, Volume 110, Issue 47, pp. 19059 - 19064
Antiangiogenic therapy has shown clear activity and improved survival benefit for certain tumor types. However, an incomplete understanding of the mechanisms... 
Oxygen | Perfusion | Glioblastoma | Biological markers | Radiotherapy | Blood | Tissue oxygenation | Tumors | Cancer | Blood plasma | VEGFR2 | VASCULAR NORMALIZATION | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | brain tumor | RADIATION | personalized treatment | TEMOZOLOMIDE | GROWTH-FACTOR RECEPTOR | ANTIANGIOGENIC THERAPY | AMPLIFICATION | MICROENVIRONMENT | TYROSINE KINASE INHIBITOR | Prospective Studies | Humans | Brain Neoplasms - pathology | Quinazolines | Glioblastoma - radiotherapy | Brain Neoplasms - metabolism | Oxygen - metabolism | DNA Repair Enzymes - metabolism | Dacarbazine - analogs & derivatives | Polymerase Chain Reaction | Statistics, Nonparametric | Glioblastoma - metabolism | Brain Neoplasms - radiotherapy | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Enzyme-Linked Immunosorbent Assay | Angiogenesis Inhibitors - pharmacology | Treatment Outcome | Brain Neoplasms - drug therapy | Receptor Protein-Tyrosine Kinases - metabolism | Biomarkers, Tumor - blood | Magnetic Resonance Imaging | Glioblastoma - pathology | Protein Kinase Inhibitors - pharmacology | Glioblastoma - drug therapy | Cancer patients | Chemotherapy | Patient outcomes | Physiological aspects | Dosage and administration | Drug therapy | Glioblastoma multiforme | Methods | Cediranib | Index Medicus | Biological Sciences
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7575, pp. 672 - 677
Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene... 
FLAVIN MONONUCLEOTIDE RIBOSWITCH | RIBOFLAVIN BIOSYNTHESIS | BACILLUS-SUBTILIS | FMN RIBOSWITCH | MULTIDISCIPLINARY SCIENCES | ESCHERICHIA-COLI | TRANSCRIPTION | GENE-EXPRESSION | STREPTOMYCES-DAVAWENSIS | ANTIBIOTIC ROSEOFLAVIN | ANTIBACTERIAL DRUG TARGETS | Bacteria - drug effects | Molecular Sequence Data | Substrate Specificity | Crystallography, X-Ray | Pyrimidines - chemistry | Heat-Shock Proteins - genetics | Pyrimidines - isolation & purification | Bacteria - growth & development | Riboswitch - genetics | Base Sequence | RNA, Bacterial - genetics | Female | Mice, Inbred DBA | Escherichia coli Infections - drug therapy | Reproducibility of Results | Riboflavin - biosynthesis | Intramolecular Transferases - genetics | Aptamers, Nucleotide - chemistry | Escherichia coli Infections - microbiology | Models, Molecular | Pyrimidines - pharmacology | Gene Expression Regulation, Bacterial - drug effects | Animals | RNA, Bacterial - drug effects | Pyrimidines - therapeutic use | RNA, Bacterial - chemistry | Riboswitch - drug effects | Bacteria - cytology | Escherichia coli Proteins - genetics | Ligands | Mice | Flavin Mononucleotide - metabolism | RNA | Gene expression | Analysis | Enzymes | Metabolites | Vitamin B | Biosynthesis | Mutation | Drug resistance | Metabolism | Ribonucleic acid--RNA | Drug dosages | Biological activity | BASIC BIOLOGICAL SCIENCES
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 4, pp. 358 - 367
Journal Article
Neurology, ISSN 0028-3878, 08/2016, Volume 87, Issue 7_Supplement_1 Suppl 1, pp. S1 - S3
The neurofibromatoses (NFs) can result in substantial morbidity in affected patients. In order to accelerate the development of effective therapies for... 
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 9/2013, Volume 114, Issue 3, pp. 257 - 262
The aim of this study was to review the literature on quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis,... 
Neurology | Medicine & Public Health | Neurofibromatosis 2 | Oncology | Neurofibromatosis 1 | Schwannomatosis | Quality of life | ONCOLOGY | TYPE-1 | CLINICAL NEUROLOGY | Neurilemmoma - therapy | Skin Neoplasms - therapy | Review Literature as Topic | Humans | Quality of Life | Adult | Neurofibromatosis 2 - therapy | Neurofibromatoses - therapy | Neurofibromatosis 1 - therapy
Journal Article